News Search Results
Mar 12, 2026, 07:30 ET Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
March 12, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent, drug-conjugation technology that creates
More news about: Intensity Therapeutics Inc.
Mar 12, 2026, 06:15 ET Epson Robots to Showcase Scalable Retail Automation at Shoptalk Spring 2026
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.
Mar 12, 2026, 03:20 ET RIMAN bringt Schwung in die 2026 North America Convention
selbst zu probieren.Darüber hinaus hielt Dr. Heesik Kim, Direktor der Cell Factory Research am Korea Research Institute of Bioscience and Biotechnology, einen Vortrag über den neuen RIMAN-Inhaltsstoff Jeju Chlorella, eine exklusive Mikroalgenart, die nicht nur für die Augengesundheit von großem
More news about: RIMAN Inc.
Mar 12, 2026, 03:01 ET GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
The Delft facility strengthens GenScript's transatlantic biotechnology infrastructure, enabling greater regional proximity, regulatory alignment, and supply chain resilience for European innovators developing next-generation
More news about: GenScript Biotech Corporation
Mar 12, 2026, 02:49 ET GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
The Delft facility strengthens GenScript's transatlantic biotechnology infrastructure, enabling greater regional proximity, regulatory alignment, and supply chain resilience for European innovators developing next-generation
More news about: GenScript Biotech Corporation
Mar 11, 2026, 17:54 ET /C O R R E C T I O N -- Bluenote/
https://en.cmicgroup.com.About BluenoteBluenote is the leading AI agentic platform for life sciences, trusted by the world's largest pharmaceutical, biotechnology, medical devices companies and CROs to transform their operations. Bluenote's AI agents streamline time-intensive, manual work across nonclinical,
More news about: Bluenote
Mar 11, 2026, 17:21 ET Scott Weidley Introduces AI-Powered Clinical Trial Build Platform as ClinCapture Advances Intelligent Trial Architecture
before enrollment begins.About ClinCaptureClinCapture develops modern clinical trial software solutions for pharmaceutical, biotechnology, medical device, and diagnostics research organizations worldwide. Its Captivate platform supports electronic data capture and advanced study workflows
More news about: ClinCapture, Inc.
Mar 11, 2026, 12:23 ET Full Circles Therapeutics Highlights Circular Single-Stranded DNA Platform Enabling Immune-Evasive Genome Writing in Nature Study
[email protected] Full Circles TherapeuticsFull Circles Therapeutics is a pioneering biotechnology company advancing genome engineering through innovative, non-viral gene editing technologies. Its proprietary cssDNA platform is designed to enable
More news about: Full Circles Therapeutics
Mar 11, 2026, 12:19 ET LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility
Australia, the new site strengthens the company's ability to support multi-regional clinical trials while helping Asia-Pacific pharmaceutical, biotechnology and clinical research organizations expand their research programs globally.
More news about: LabConnect
Mar 11, 2026, 12:04 ET LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility
Australia, the new site strengthens the company's ability to support multi-regional clinical trials while helping Asia-Pacific pharmaceutical, biotechnology and clinical research organizations expand their research programs globally.
More news about: LabConnect
Mar 11, 2026, 11:45 ET REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
and independence, required support for breathing, cardiomyopathy and premature death.ABOUT REGENXBIO Inc.REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Mar 11, 2026, 11:31 ET Dearomatic Solvents Market to Reach US$ 3.5 Billion by 2033 Driven by Sustainable Chemical Adoption - Persistence Market Research
Formulation, Cleaning and Purification, Research & Development (R&D), Others), End-User (Pharmaceutical Companies, Generic Drug Manufacturers, Biotechnology Companies, Contract Research Organizations (CROs)), and Regional Analysis for 2026-2033
More news about: Persistence Market Research Pvt. Ltd.
Mar 11, 2026, 09:20 ET Longevity Medical Institute® Physicians and Scientists Publish Peer-Reviewed Research on Stem Cell Therapies for Diabetic Foot Ulcers
regenerative medicine infrastructure. The Institute recently announced the opening of a federally licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory in Los Cabos operating under COFEPRIS, Mexico's national health regulatory authority. The facility supports physician-directed regenerative
More news about: Longevity Medical Institute LLC
Mar 11, 2026, 09:00 ET Andel Launches New Direct-to-Employer Medication Platform to Make GLP-1s Affordable for Millions
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Andel Co-op, Inc.
Mar 11, 2026, 08:59 ET Immorta Bio Demonstrates Dramatic Lifespan Extension in Aging Mouse Models; Research Accepted for Presentation at AAI's IMMUNOLOGY2026
MIAMI, March 11, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced breakthrough preclinical results demonstrating dramatic
More news about: Immorta Bio Inc.
Mar 11, 2026, 08:30 ET Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform
HOUSTON, March 11, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to work across multiple viruses, today announced a
More news about: Decoy Therapeutics, Inc
Mar 11, 2026, 07:37 ET Prior Authorization May Hinder Access to Lifesaving Heart Failure Medications
School in Boston, and Ian Kronish, MD, MPH, at Columbia University in New York City.Reynolds has received funding for unrelated research from biotechnology companies Abbott, Philips, and Siemens. NYU Langone Health is managing the terms and conditions of these relationships in accordance with its policies
More news about: NYU Grossman School of Medicine and NYU Langone Health
Mar 11, 2026, 06:00 ET Yatsen Announces Private Placement of Convertible Notes and Warrants
packaging providers, which serves many prestigious global brands. Furthermore, Trustar Capital's extensive footprint in the pharmaceutical and biotechnology sectors positions it to provide critical support for the Company's cutting-edge product R&D. Trustar Capital also brings a proven track record
More news about: Yatsen Holding Limited
Mar 11, 2026, 04:00 ET ARTHEx Biotech Granted FDA Fast Track Designation for ATX-01 for the Treatment of Myotonic Dystrophy Type 1 (DM1)
VALENCIA, Spain, March 11, 2026 /PRNewswire/ -- ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted
More news about: ARTHEx Biotech
Mar 11, 2026, 03:48 ET Silicon Leads the Radiation Hardened Electronics Market with 64.27% Share in 2025 as the Market Reaches USD 2.33 Billion by 2031, Reports Mordor Intelligence
of 4.68%. Growth is driven by rising demand for contamination-controlled environments in semiconductor manufacturing, pharmaceuticals, and biotechnology facilities. Increasing investments in advanced manufacturing infrastructure and strict regulatory standards are further supporting market expansion. Signify
More news about: Mordor Intelligence Private Limited
Mar 10, 2026, 21:52 ET RIMAN Ignites Momentum at 2026 North America Convention
products for themselves.In addition, Dr. Heesik Kim, Director of Cell Factory Research at the Korea Research Institute of Bioscience and Biotechnology, delivered an advanced lecture on RIMAN's new heritage ingredient, Jeju Chlorella, an exclusive microalga species with robust benefits in ocular
More news about: RIMAN Inc.
Mar 10, 2026, 21:22 ET RIMAN Ignites Momentum at 2026 North America Convention
products for themselves.In addition, Dr. Heesik Kim, Director of Cell Factory Research at the Korea Research Institute of Bioscience and Biotechnology, delivered an advanced lecture on RIMAN's new heritage ingredient, Jeju Chlorella, an exclusive microalga species with robust benefits in ocular
More news about: RIMAN Inc.
Mar 10, 2026, 20:02 ET China Agricultural Machinery Market Poised for Strong Growth, Expected to Reach USD 36.2 Billion by 2032 | MarkNtel Advisors
India Agricultural Biotechnology Market: The India Agricultural Biotechnology market size was valued at around USD 3.0 billion in 2025 and is projected to grow from USD 4.5 billion in 2026 to USD
More news about: MarkNtel Advisors
Mar 10, 2026, 12:35 ET AcuraStem Awarded Target ALS Grant to Advance Therapeutics Targeting a Core Driver of ALS
PASADENA, Calif., March 10, 2026 /PRNewswire/ -- AcuraStem, a patient-based biotechnology company developing disease-modifying therapies for amyotrophic lateral sclerosis (ALS), today announced it has received a two-year research grant
More news about: AcuraStem - Patient-Based Therapeutics
Mar 10, 2026, 11:07 ET Longevity Medical Institute® Opens AI-Enhanced Full-Body MRI Program in Los Cabos
diagnostics, and physician-directed longevity care.The Institute currently operates:A federally licensed on-site stem cell biotechnology laboratoryA fully integrated surgical centerAn in-house clinical laboratory measuring more than 120 biomarkersAdvanced
More news about: Longevity Medical Institute LLC